A
Arquer Diagnostics
Arquer Diagnostics is a diagnostics company focused on the development and commercialisation of a non-invasive immunoassay diagnostic test
About Arquer Diagnostics
Arquer Diagnostics is a UK-based, female-led company specializing in the development and commercialization of non-invasive, highly accurate, and cost-effective cancer biomarker tests. The company operates in the oncology diagnostics market, focusing on transforming how patients are diagnosed with cancer and monitored throughout their treatment journey. Arquer Diagnostics serves healthcare providers, particularly urologists, who can order their flagship product, ADXBLADDER, through distribution partners. The business model revolves around the sale of these diagnostic tests, which are designed to detect cancer biomarkers in bodily fluids such as urine. Revenue is generated through direct sales to healthcare providers and partnerships with distribution channels. The company is supported by internationally recognized clinical advisors who guide their research programs, clinical studies, and dissemination of clinical information.
Source: Dealroom company dataAt a glance
- Founded
- 2006
- Headquarters
- Sunderland, United Kingdom
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Longwall Ventures
Northstar Ventures
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Arquer Diagnostics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arquer Diagnostics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.